Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:2591
doi: 10.1161/CIRCULATIONAHA.107.183528
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles

(Circulation. 2007;115:2591.)
© 2007 American Heart Association, Inc.

Issue Highlights


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    RISK OF THROMBOEMBOLISM IN HEART FAILURE: AN ANALYSIS FROM THE SUDDEN CARDIAC DEATH IN HEART FAILURE TRIAL (SCD-HeFT), by Freudenberger et al.
 
In the current issue of Circulation, Freudenberger and colleagues evaluated the incidence of thromboembolism in patients with heart failure who did not have atrial fibrillation or a prosthetic heart valve. An analysis of 2144 patients who participated in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) demonstrated that the risk of thromboembolism, including stroke, pulmonary embolization, or peripheral embolization, was approximately 1.7% per year, without antiarrhythmic therapy. In this cohort of patients with moderately stable symptomatic heart failure and an ejection fraction <0.35%, the incidence of clinical thromboembolism events was low and dependent on the level of left ventricular dysfunction at baseline. In addition, rates of thromboembolism were lower in patients randomized to amiodarone or implantable cardioverter-defibrillator devices compared to those randomized to placebo. Taken together, these data suggest that strategies for the prevention of thromboembolism in patients with heart failure may be possible. See p 2637.


*    CASE VOLUME AND MORTALITY IN PEDIATRIC CARDIAC SURGERY PATIENTS IN CALIFORNIA, 1998–2003, by Bazzani and Marcin
 
Annual surgical case volume for congenital heart surgery has been reported to be inversely related to in-hospital mortality. Recent studies have suggested that the magnitude of association between mortality and case volume may be decreasing with time. Bazzani and Marcin reassess the hospital case volume–outcome relationship in California among pediatric cardiac surgery patients, using a more contemporary data set than previous investigations. Older models no longer predicted a consistent case volume–mortality relationship. Using a new model, increasing hospital volume was associated significantly with lower mortality, but this relationship was highly dependent upon the single institution in California performing >400 surgical . . . [Full Text of this Article]


Related Articles:

Reevaluation of the Volume-Outcome Relationship for Pediatric Cardiac Surgery
Kimberlee Gauvreau
Circulation 2007 115: 2599-2601. [Extract] [Full Text]

Recanalization and Stroke Outcome
Gregory J. del Zoppo and James A. Koziol
Circulation 2007 115: 2602-2605. [Extract] [Full Text]

A Magic Bullet Through the Heart
Numan Ali Aydemir, Ihsan Bakir, Firat Altin, Sinan Sahin, and Mehmet Salih Bilal
Circulation 2007 115: e467-e468. [Extract] [Full Text]

Wolff-Parkinson-White Syndrome and Atrial Fibrillation in a Patient With a Coronary Sinus Diverticulum
Robert Blank, Thomas Dieterle, Stefan Osswald, and Christian Sticherling
Circulation 2007 115: e469-e471. [Extract] [Full Text]

Duration of Discharge of Neuromuscular Incapacitating Device and Inappropriate Implantable Cardioverter-Defibrillator Detections
Rajneesh Calton, Douglas Cameron, Stephane Masse, and Kumaraswamy Nanthakumar
Circulation 2007 115: e472-e474. [Extract] [Full Text]

Letter by Ridker and Everett Regarding Article, "The Inflammatory Hypothesis: Any Progress in Risk Stratification and Therapeutic Targets?"
Paul M Ridker and Brendan M. Everett
Circulation 2007 115: e475. [Extract] [Full Text]

Risk of Thromboembolism in Heart Failure: An Analysis From the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
Ronald S. Freudenberger, Anne S. Hellkamp, Jonathan L. Halperin, Jeanne Poole, Jill Anderson, George Johnson, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy for the SCD-HeFT Investigators
Circulation 2007 115: 2637-2641. [Abstract] [Full Text]